![WO2004110398A1 - Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof - Google Patents WO2004110398A1 - Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof - Google Patents](https://patentimages.storage.googleapis.com/4f/50/72/96d655e209c6d9/imgf000020_0001.png)
WO2004110398A1 - Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof - Google Patents
![WO2004110398A1 - Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof - Google Patents WO2004110398A1 - Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof - Google Patents](https://patentimages.storage.googleapis.com/ef/bb/1f/d41da8a542c4e1/imgf000014_0001.png)
WO2004110398A1 - Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof - Google Patents
![Directed pharmacological therapy of ambiguous genitalia due to an androgen receptor gene mutation - The Lancet Directed pharmacological therapy of ambiguous genitalia due to an androgen receptor gene mutation - The Lancet](https://www.thelancet.com/cms/attachment/4c0e0734-1549-40e3-8091-865b5c902bc1/gr1.gif)
Directed pharmacological therapy of ambiguous genitalia due to an androgen receptor gene mutation - The Lancet
![EP1317921A1 - Gel or solution containing dihydrotestosterone, its manufacture and use - Google Patents EP1317921A1 - Gel or solution containing dihydrotestosterone, its manufacture and use - Google Patents](https://patentimages.storage.googleapis.com/59/a7/12/59129bb50a88f7/00140001.png)